Literature DB >> 17135636

Dasatinib induces a response in malignant thymoma.

Charles Chuah, Tse Hui Lim, Alvin Soon Tiong Lim, Sim Leng Tien, Chong Hee Lim, Richie Soong, Francis Lee, Yeh Ching Linn, Yeow Tee Goh, Foong Koon Cheah, Alwin Hwai Liang Loh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17135636     DOI： 10.1200/JCO.2006.08.8963

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Authors:  Hyun-Sung Lee; Hee-Jin Jang; Rohan Shah; David Yoon; Masatsugu Hamaji; Ori Wald; Ju-Seog Lee; David J Sugarbaker; Bryan M Burt
Journal:  Clin Cancer Res       Date:  2017-04-11       Impact factor: 12.531

2.  Platelet-derived growth factor and platelet-derived growth factor receptor-α expression in the normal human thymus and thymoma.

Authors:  Anca Maria Cimpean; Raluca Ceauşu; Svetlana Encică; Pusa Nela Gaje; Domenico Ribatti; Marius Raica
Journal:  Int J Exp Pathol       Date:  2011-06-07       Impact factor: 1.925

3.  Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience.

Authors:  P Ströbel; R Bargou; A Wolff; D Spitzer; C Manegold; A Dimitrakopoulou-Strauss; L Strauss; C Sauer; F Mayer; P Hohenberger; A Marx
Journal:  Br J Cancer       Date:  2010-06-22       Impact factor: 7.640

Review 4.  Treatment of advanced thymoma and thymic carcinoma.

Authors:  Arun Rajan; Giuseppe Giaccone
Journal:  Curr Treat Options Oncol       Date:  2009-04-21

5.  Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.

Authors:  Nicolas Girard; Ronglai Shen; Tianhua Guo; Maureen F Zakowski; Adriana Heguy; Gregory J Riely; James Huang; Christopher Lau; Alex E Lash; Marc Ladanyi; Agnes Viale; Cristina R Antonescu; William D Travis; Valerie W Rusch; Mark G Kris; William Pao
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

6.  Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort.

Authors:  Somayye Taghvaei; Farzaneh Sabouni; Zarrin Minuchehr
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

Review 7.  [Research status of molecular targeted therapy in thymic epithelial tumors].

Authors:  Lizhu Chen; Kailiang Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.